{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:48:25Z","timestamp":1793792905399,"version":"4.6.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR059103"],"award-info":[{"award-number":["R01 AR059103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012541","name":"Guangdong Innovative and Entrepreneurial Research Team Program","doi-asserted-by":"publisher","award":["2016ZT06S252"],"award-info":[{"award-number":["2016ZT06S252"]}],"id":[{"id":"10.13039\/100012541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901657"],"award-info":[{"award-number":["81901657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671611"],"award-info":[{"award-number":["81671611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871224"],"award-info":[{"award-number":["81871224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.autrev.2020.102743","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T06:09:39Z","timestamp":1608098979000},"page":"102743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":205,"title":["An updated advance of autoantibodies in autoimmune diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Ze Xiu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Guo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102743_bb0005","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1172\/JCI97965","article-title":"Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation","volume":"128","author":"Zou","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.autrev.2020.102743_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cmi.2016.60","article-title":"uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K\/Akt signaling pathway in patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0015","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2105\/AJPH.90.9.1463","article-title":"Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States","volume":"90","author":"Walsh","year":"2000","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.autrev.2020.102743_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102532","article-title":"Comprehensive meta-analysis reveals an association of the HLA-DRB1*1602 allele with autoimmune diseases mediated predominantly by autoantibodies","volume":"19","author":"Chen","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2019.03.013","article-title":"Influence of HLA-DRB1 susceptibility alleles on the autoantibodies spectrum of systemic lupus erythematosus in European part of Russia","volume":"18","author":"Tkachenko","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102348","article-title":"Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities","volume":"18","author":"Mane-Damas","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2020.102743_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2008.06.005","article-title":"Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other","volume":"29","author":"Horwitz","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102743_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102506","article-title":"Precision medicine in the care of rheumatoid arthritis: focus on prediction and prevention of future clinically-apparent disease","volume":"19","author":"Mahler","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102508","article-title":"Precision health: a pragmatic approach to understanding and addressing key factors in autoimmune diseases","volume":"19","author":"Conrad","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102515","article-title":"Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels","volume":"19","author":"Smeets","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102450","article-title":"Autoantigenomics: holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases","volume":"19","author":"Moritz","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0070","series-title":"xPharm: The comprehensive pharmacology reference","first-page":"1","article-title":"Immunoglobulins","author":"Grattendick","year":"2007"},{"issue":"2016","key":"10.1016\/j.autrev.2020.102743_bb0075","first-page":"3631","article-title":"TGF-\u03b2-induced regulatory T cells directly suppress B cell responses through a noncytotoxic mechanism","volume":"196","author":"Xu","year":"1950","journal-title":"J. Immunol. (Baltimore, Md.)"},{"key":"10.1016\/j.autrev.2020.102743_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102422","article-title":"Aetiology and pathogenesis of paraneoplastic autoimmune disorders","volume":"19","author":"Geng","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2018.12.005","article-title":"Lethal immunoglobulins: autoantibodies and sudden cardiac death","volume":"18","author":"Ryabkova","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0090","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ymthe.2019.07.014","article-title":"CD8+CD103+ iTregs inhibit chronic graft-versus-host disease with lupus nephritis by the increased expression of CD39","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol. Thera.: J. Am. Soc. Gene Thera."},{"key":"10.1016\/j.autrev.2020.102743_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crisp\u00edn","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.autrev.2020.102743_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102386","article-title":"Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios","volume":"18","author":"Bossuyt","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti-Ro and anti-La antibodies in primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Hern\u00e1ndez-Molina","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF02205562","article-title":"Anti-centromere antibodies (ACA)","volume":"9","author":"Kallenberg","year":"1990","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.autrev.2020.102743_bb0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.autrev.2007.12.001","article-title":"Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms","volume":"7","author":"Yung","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s100670070030","article-title":"Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations","volume":"19","author":"Schmidt","year":"2000","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.autrev.2020.102743_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","article-title":"Autoantibodies in the diagnosis of systemic rheumatic diseases","volume":"24","author":"von M\u00fchlen","year":"1995","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.autrev.2020.102743_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102465","article-title":"Anti-RNP antibodies delineate a subgroup of myositis: a systematic retrospective study on 46 patients","volume":"19","author":"Wesner","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1568-9972(03)00018-1","article-title":"The anti-Sm immune response in autoimmunity and cell biology","volume":"2","author":"Zieve","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2010.06.005","article-title":"Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality?","volume":"9","author":"Mahler","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autrev.2010.07.005","article-title":"Drug-induced lupus: an update","volume":"10","author":"Katz","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1083\/jcb.134.3.589","article-title":"Molecular and functional characterization of the p62 complex, an assembly of nuclear pore complex glycoproteins","volume":"134","author":"Hu","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.autrev.2020.102743_bb0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1600-0528.2002.017410.x","article-title":"The peculiar autoimmunity of primary biliary cirrhosis","volume":"174","author":"Mackay","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102355","article-title":"Interstitial lung disease associated with anti-PM-Scl antibody: a single center experience","volume":"18","author":"Ussavarungsi","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0175","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.autrev.2019.05.002","article-title":"Anti-OJ autoantibodies: Rare or underdetected?","volume":"18","author":"Vulsteke","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-8529(05)70189-4","article-title":"Thyroid autoantibodies","volume":"30","author":"Saravanan","year":"2001","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.autrev.2020.102743_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2003.09.013","article-title":"Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies","volume":"65","author":"Reumaux","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0190","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2000.057003846.x","article-title":"Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features","volume":"57","author":"Savige","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.autrev.2020.102743_bb0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/clin.1994.1018","article-title":"Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes","volume":"70","author":"Shibata","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.autrev.2020.102743_bb0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360701295623","article-title":"Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts","volume":"44","author":"Raptopoulou","year":"2007","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.autrev.2020.102743_bb0205","first-page":"83","article-title":"Significance of smooth muscle\/anti-actin autoantibodies in celiac disease","volume":"35","author":"Pedreira","year":"2005","journal-title":"Acta Gastroenterol. Latinoam."},{"key":"10.1016\/j.autrev.2020.102743_bb0210","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.autrev.2018.06.011","article-title":"The clinical value of assays detecting antibodies against domain I of beta2-glycoprotein I in the antiphospholipid syndrome","volume":"17","author":"Yin","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0215","first-page":"142","article-title":"Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms","volume":"316","author":"Rand","year":"1998","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2020.102743_bb0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.2.5867.643","article-title":"Immunoglobulin deposition in liver of patients with active chronic hepatitis and antibody against smooth muscle","volume":"2","author":"Dawkins","year":"1973","journal-title":"Br. Med. J."},{"key":"10.1016\/j.autrev.2020.102743_bb0225","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatol. (Baltimore, Md)"},{"key":"10.1016\/j.autrev.2020.102743_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102389","article-title":"Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: results of an Italian multicenter study","volume":"18","author":"Bonaguri","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1042\/bst0050174","article-title":"The reactivity of anti-ganglioside antiserum with isolated cerebellar cells","volume":"5","author":"Gregson","year":"1977","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.autrev.2020.102743_bb0240","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2020.102743_bb0250","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2018.09.008","article-title":"Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy","volume":"18","author":"Anquetil","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0260","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102743_bb0265","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410430520","article-title":"Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome","volume":"43","author":"Houzen","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.autrev.2020.102743_bb0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1083\/jcb.124.1.161","article-title":"Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading","volume":"124","author":"Carey","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.autrev.2020.102743_bb0275","doi-asserted-by":"crossref","first-page":"38216","DOI":"10.1038\/srep38216","article-title":"Anti-Hu antibodies activate enteric and sensory neurons","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.autrev.2020.102743_bb0280","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2011","key":"10.1016\/j.autrev.2020.102743_bb0285","first-page":"3421","article-title":"Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus","volume":"186","author":"Huang","year":"1950","journal-title":"J. Immunol. (Baltimore, Md.)"},{"key":"10.1016\/j.autrev.2020.102743_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-3083.2001.00959.x","article-title":"Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus","volume":"54","author":"Arbuckle","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.1999.tb01310.x","article-title":"The central and multiple roles of B cells in lupus pathogenesis","volume":"169","author":"Chan","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0305","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0961203319829818","article-title":"The essential role of costimulatory molecules in systemic lupus erythematosus","volume":"28","author":"Xiao","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102743_bb0310","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2016.00604","article-title":"Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms","volume":"7","author":"Luo","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0315","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41584-018-0036-2","article-title":"Hormone status regulates autoantibody pathogenicity","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.autrev.2020.102743_bb0320","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/ard.2005.039438","article-title":"Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus","volume":"65","author":"Freemer","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0325","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102743_bb0330","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fimmu.2018.00702","article-title":"Long non-coding RNA GAPLINC promotes tumor-like biologic behaviors of fibroblast-like synoviocytes as MicroRNA sponging in rheumatoid arthritis patients","volume":"9","author":"Mo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0335","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fimmu.2017.00159","article-title":"Smoothened regulates migration of fibroblast-like synoviocytes in rheumatoid arthritis via activation of rho GTPase signaling","volume":"8","author":"Peng","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0340","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0463.2007.apm_682a.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. 1939","volume":"115","author":"Waaler","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.autrev.2020.102743_bb0345","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0350","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/qjmed\/hcp165","article-title":"Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies","volume":"103","author":"Song","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2020.102743_bb0355","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2004.023523","article-title":"Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis","volume":"64","author":"De Rycke","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0365","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.autrev.2020.102743_bb0370","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autrev.2020.102743_bb0375","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1172\/JCI25265","article-title":"BLyS and APRIL in rheumatoid arthritis","volume":"115","author":"Seyler","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2005","key":"10.1016\/j.autrev.2020.102743_bb0380","first-page":"864","article-title":"Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines","volume":"174","author":"Ohata","year":"1950","journal-title":"J. Immunol. (Baltimore, Md.)"},{"key":"10.1016\/j.autrev.2020.102743_bb0385","doi-asserted-by":"crossref","first-page":"e23629","DOI":"10.1371\/journal.pone.0023629","article-title":"BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102743_bb0390","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cytogfr.2013.12.011","article-title":"The function of BAFF on T helper cells in autoimmunity","volume":"25","author":"Chen","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0395","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/cmi.2012.18","article-title":"The development and function of follicular helper T cells in immune responses","volume":"9","author":"Chen","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0400","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.trre.2018.07.002","article-title":"Advances in T follicular helper and T follicular regulatory cells in transplantation immunity","volume":"32","author":"Chen","year":"2018","journal-title":"Transplant Rev. (Orlando)"},{"key":"10.1016\/j.autrev.2020.102743_bb0405","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.autrev.2018.02.014","article-title":"ACPA mediates the interplay between innate and adaptive immunity in rheumatoid arthritis","volume":"17","author":"Dong","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0410","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2018-214950","article-title":"Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification","volume":"78","author":"Kampstra","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0415","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2016-209297","article-title":"Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs","volume":"76","author":"Figueiredo","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0420","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/540S1a","article-title":"Multiple sclerosis","volume":"540","author":"Owens","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102743_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104468","article-title":"Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis","volume":"129","author":"Zeng","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.autrev.2020.102743_bb0430","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2018.09.003","article-title":"Novel autoantibodies in Sjogren\u2019s syndrome: a comprehensive review","volume":"18","author":"Martin-Nares","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0435","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbadis.2010.06.009","article-title":"The role of antibodies in multiple sclerosis","volume":"1812","author":"Weber","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0440","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1073\/pnas.1519608113","article-title":"Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease","volume":"113","author":"Flach","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.autrev.2020.102743_bb0445","first-page":"5673","article-title":"Mesenchymal stromal cells attenuate multiple sclerosis via IDO-dependent increasing the suppressive proportion of CD5+ IL-10+ B cells","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.autrev.2020.102743_bb0450","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1038\/540S97a","article-title":"Inflammatory bowel disease","volume":"540","author":"Hodson","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102743_bb0455","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.autrev.2014.01.029","article-title":"Diagnosis and classification of Crohn's disease","volume":"13","author":"Laass","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0460","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2020.102743_bb0465","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2020.102743_bb0470","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fcell.2019.00285","article-title":"Mesenchymal stem cells: allogeneic MSC may be immunosuppressive but autologous MSC are dysfunctional in lupus patients","volume":"7","author":"Cheng","year":"2019","journal-title":"Front. Cell Develop. Biol."},{"key":"10.1016\/j.autrev.2020.102743_bb0475","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/art.37894","article-title":"Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2020.102743_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.12.1926","article-title":"Culture medium from TNF-\u03b1-stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms","volume":"136","author":"Su","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0485","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ebiom.2019.04.058","article-title":"Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis","volume":"43","author":"Luo","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.autrev.2020.102743_bb0490","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fimmu.2017.00068","article-title":"Human gingiva-derived mesenchymal stem cells inhibit Xeno-graft-versus-host disease via CD39-CD73-adenosine and IDO signals","volume":"8","author":"Huang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0495","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41551-019-0360-0","article-title":"Depletion of PD-1-positive cells ameliorates autoimmune disease","volume":"3","author":"Zhao","year":"2019","journal-title":"Natur. Biomed. Eng."},{"key":"10.1016\/j.autrev.2020.102743_bb0500","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2020.102743_bb0505","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.autrev.2020.102743_bb0510","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill B lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102743_bb0515","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2018.00035","article-title":"TGF-\u03b2-induced CD8(+)CD103(+) regulatory T cells show potent therapeutic effect on chronic graft-versus-host disease lupus by suppressing B cells","volume":"9","author":"Zhong","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2020.102743_bb0520","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3389\/fimmu.2017.01334","article-title":"In vivo attenuation of antibody-mediated acute renal allograft rejection by ex vivo TGF-\u03b2-induced CD4(+)Foxp3(+) regulatory T cells","volume":"8","author":"Liao","year":"2017","journal-title":"Front. Immunol."},{"issue":"192","key":"10.1016\/j.autrev.2020.102743_bb0525","first-page":"4069","article-title":"Regulatory CD4+ T cells promote B cell anergy in murine lupus","volume":"1950","author":"Liu","year":"2014","journal-title":"J. Immunol. (Baltimore, Md.)"},{"key":"10.1016\/j.autrev.2020.102743_bb0530","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jmcb\/mjt026","article-title":"Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells","volume":"6","author":"Liu","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.autrev.2020.102743_bb0535","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/art.34513","article-title":"Antigen-specific transforming growth factor \u03b2-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17\/Treg cell balance from Th17 predominance to Treg cell predominance","volume":"64","author":"Kong","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2020.102743_bb0540","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.celrep.2019.01.066","article-title":"Negligible effect of sodium chloride on the development and function of TGF-\u03b2-induced CD4(+) Foxp3(+) regulatory T cells","volume":"26","author":"Luo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.autrev.2020.102743_bb0545","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1172\/JCI81151","article-title":"Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells","volume":"125","author":"Hernandez","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"2008","key":"10.1016\/j.autrev.2020.102743_bb0550","first-page":"7112","article-title":"Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6","volume":"180","author":"Zheng","year":"1950","journal-title":"J. Immunol. (Baltimore, Md.)"},{"key":"10.1016\/j.autrev.2020.102743_bb0555","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2011-201052","article-title":"Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells","volume":"71","author":"Kong","year":"2012","journal-title":"Ann. Rheum. Dis."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:42Z","timestamp":1761600102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220303244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1568997220303244"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102743","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An updated advance of autoantibodies in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102743"}}